Entries of Wright, Jonathan L. on the publication server
 | Up a level |
Number of items: 3.
2023
Gil-Jimenez, Alberto, van Dorp, Jeroen 
, Contreras-Sanz, Alberto, van der Vos, Kristan, Vis, Daniel J., Braaf, Linde, Broeks, Annegien, Kerkhoven, Ron, van Kessel, Kim E.M., Ribal, María José, Alcaraz, Antonio, Wessels, Lodewyk F.A., Seiler, Roland, Wright, Jonathan L., Mengual, Lourdes, Boormans, Joost, van Rhijn, Bas W.G., Black, Peter C. and van der Heijden, Michiel S.
(2023)
Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer.
European Urology 83 (4), pp. 313-317.
Fulltext not available.
, Contreras-Sanz, Alberto, van der Vos, Kristan, Vis, Daniel J., Braaf, Linde, Broeks, Annegien, Kerkhoven, Ron, van Kessel, Kim E.M., Ribal, María José, Alcaraz, Antonio, Wessels, Lodewyk F.A., Seiler, Roland, Wright, Jonathan L., Mengual, Lourdes, Boormans, Joost, van Rhijn, Bas W.G., Black, Peter C. and van der Heijden, Michiel S.
(2023)
Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer.
European Urology 83 (4), pp. 313-317.
Fulltext not available.
Gil-Jimenez, Alberto, van Dorp, Jeroen, Contreras-Sanz, Alberto, van der Vos, Kristan, Vis, Daniel J., Braaf, Linde, Broeks, Annegien, Kerkhoven, Ron, van Kessel, Kim E.M., Ribal, María José, Alcaraz, Antonio, Wessels, Lodewyk F.A., Seiler, Roland, Wright, Jonathan L., Mengual, Lourdes, Boormans, Joost, van Rhijn, Bas W.G., Black, Peter C. and van der Heijden, Michiel S.
(2023)
Corrigendum to “Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer” [Eur Urol 2023;83:313–17].
European Urology 83 (6), e165.
Fulltext not available.
2022
Einerhand, Sarah M. H., Black, Anna J., Zargar, Homayoun , Fairey, Adrian S., Dinney, Colin P., Mir, Maria C., Krabbe, Laura-Maria, Cookson, Michael S., Jacobson, Niels-Erik, Montgomery, Jeffrey S., Vasdev, Nikhil , Yu, Evan Y., Xylinas, Evanguelos, Kassouf, Wassim, Dall’Era, Marc A., Sridhar, Srikala S., McGrath, Jonathan S., Aning, Jonathan, Shariat, Shahrokh F., Wright, Jonathan L., Thorpe, Andrew C., Morgan, Todd M. , Holzbeierlein, Jeff M., Bivalacqua, Trinity J., North, Scott, Barocas, Daniel A., Lotan, Yair, Grivas, Petros, Garcia, Jorge A., Stephenson, Andrew J., Shah, Jay B., Daneshmand, Siamak, Zargar-Shoshtari, Kamran, Spiess, Philippe E., van Rhijn, Bas W. G., Black, Peter C. and Mertens, Laura S.
(2022)
Multicenter evaluation of neoadjuvant and induction gemcitabine–carboplatin versus gemcitabine–cisplatin followed by radical cystectomy for muscle-invasive bladder cancer.
World Journal of Urology 40 (11), pp. 2707-2715.
Fulltext not available.
, Fairey, Adrian S., Dinney, Colin P., Mir, Maria C., Krabbe, Laura-Maria, Cookson, Michael S., Jacobson, Niels-Erik, Montgomery, Jeffrey S., Vasdev, Nikhil , Yu, Evan Y., Xylinas, Evanguelos, Kassouf, Wassim, Dall’Era, Marc A., Sridhar, Srikala S., McGrath, Jonathan S., Aning, Jonathan, Shariat, Shahrokh F., Wright, Jonathan L., Thorpe, Andrew C., Morgan, Todd M. , Holzbeierlein, Jeff M., Bivalacqua, Trinity J., North, Scott, Barocas, Daniel A., Lotan, Yair, Grivas, Petros, Garcia, Jorge A., Stephenson, Andrew J., Shah, Jay B., Daneshmand, Siamak, Zargar-Shoshtari, Kamran, Spiess, Philippe E., van Rhijn, Bas W. G., Black, Peter C. and Mertens, Laura S.
(2022)
Multicenter evaluation of neoadjuvant and induction gemcitabine–carboplatin versus gemcitabine–cisplatin followed by radical cystectomy for muscle-invasive bladder cancer.
World Journal of Urology 40 (11), pp. 2707-2715.
Fulltext not available.